Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by barcodewhizon Mar 08, 2018 3:18pm
264 Views
Post# 27685882

RE:RE:RE:RE:RBC

RE:RE:RE:RE:RBCThats a really informative thread thx!

those historical odds just re enforces to me that the likelihood of an outright rejection is minimal... almost Black Swan at this point.  Lets hope for an outright approval and voucher by pdufa date, and if there turns out to be some further normal course delays then so be it.  Still on the path to a very very positive and game changing outcome....and that doesnt even consider the very real possibility that these guys have stumbled on/developed a molecule that REVERSES fibrosis/ cracked the fibrosis code as the KOL’s stated.  Whats that worth in combo therapy with Ryplazim for IPF and AlI?  My guess is we are about to find out despite all this fear and teeth gnashing
Bullboard Posts